Information Journal Paper
APA:
Copy. (2021). Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes. STEM CELL RESEARCH AND THERAPY, 12(1), 0-0. SID. https://sid.ir/paper/1090221/en
Vancouver:
Copy. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes. STEM CELL RESEARCH AND THERAPY[Internet]. 2021;12(1):0-0. Available from: https://sid.ir/paper/1090221/en
IEEE:
Copy, “Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes,” STEM CELL RESEARCH AND THERAPY, vol. 12, no. 1, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/1090221/en